IOL Chemicals and Pharmaceuticals Submits Q4FY26 SDD Compliance Certificate to Stock Exchanges

1 min read     Updated on 22 Apr 2026, 08:32 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

IOL Chemicals and Pharmaceuticals Limited filed its Q4FY26 SDD compliance certificate with NSE and BSE on 17th April 2026, confirming full adherence to SEBI's Prohibition of Insider Trading Regulations. The company achieved 100% compliance by capturing 1 out of 1 required events during the quarter with no non-compliance issues reported, demonstrating robust corporate governance and regulatory adherence.

powered bylight_fuzz_icon
38372556

*this image is generated using AI for illustrative purposes only.

IOL Chemicals & Pharmaceuticals Limited has submitted its quarterly compliance certificate for Structured Digital Database (SDD) to both the National Stock Exchange of India and BSE Limited on 17th April 2026. The certificate pertains to the quarter ended 31st March 2026 and demonstrates the company's adherence to regulatory requirements under SEBI's Prohibition of Insider Trading Regulations.

Regulatory Compliance Framework

The compliance certificate was filed pursuant to Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Sr Vice President Abhay Raj Singh, serving as the Compliance Officer, certified the company's full compliance with SDD requirements.

Key Compliance Parameters

The certificate confirms IOL Chemicals and Pharmaceuticals Limited meets all essential SDD requirements:

Compliance Parameter Status
Structured Digital Database in place ✓ Compliant
Access controls implemented ✓ Compliant
UPSI capture in database ✓ Compliant
Nature, date and time recording ✓ Compliant
Internal maintenance with audit trail ✓ Compliant
Non-tamperable system with 8-year retention ✓ Compliant

Event Tracking and Performance

During the quarter ended 31st March 2026, the company was required to capture 1 event and successfully recorded 1 event, achieving 100.00% compliance rate. This demonstrates effective implementation of the company's insider trading prevention mechanisms.

Non-Compliance Status

The compliance certificate reported zero non-compliance issues for the quarter:

Sr. No. Particulars of noncompliance Remedial action
- Nil N/a

Corporate Governance Excellence

The timely submission of the SDD compliance certificate reflects IOL Chemicals and Pharmaceuticals Limited's commitment to maintaining high standards of corporate governance and regulatory compliance. The company's robust internal control systems ensure proper handling of Unpublished Price Sensitive Information (UPSI) and adherence to SEBI's insider trading prevention framework.

The certificate was digitally signed and submitted from the company's Ludhiana office, maintaining transparency in corporate communications with stock exchanges and regulatory authorities.

Historical Stock Returns for IOL Chemicals & Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.08%+12.99%+27.96%0.0%+41.23%-22.23%

Will SEBI introduce more stringent SDD requirements or additional compliance parameters for pharmaceutical companies in the upcoming regulatory review cycle?

How might IOL Chemicals' strong compliance track record influence investor confidence and institutional investment decisions in the next quarter?

Could the company's robust insider trading prevention mechanisms provide a competitive advantage when pursuing strategic partnerships or acquisitions?

IOL Chemicals & Pharmaceuticals
View Company Insights
View All News
like19
dislike

IOL Chemicals Opens Special Window for Physical Share Transfer and Dematerialisation

2 min read     Updated on 13 Apr 2026, 04:54 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

IOL Chemicals and Pharmaceuticals Limited has opened a special window from February 5, 2026 to February 4, 2027 for physical share transfer and dematerialisation under SEBI guidelines. The facility covers transfer deeds executed before April 1, 2019, including previously rejected requests and unlodged cases. All processed shares will be in dematerialised form with a one-year lock-in period.

powered bylight_fuzz_icon
37625088

*this image is generated using AI for illustrative purposes only.

IOL Chemicals and Pharmaceuticals Limited has announced the opening of a special window for shareholders holding physical securities to facilitate transfer and dematerialisation processes. The company published newspaper advertisements in Financial Express (English) and Punjabi Jagran (Punjabi) on April 11, 2026, informing stakeholders about this regulatory compliance initiative.

Special Window Details

Pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/1/3750/2026 dated January 30, 2026, the company has opened a one-time special window for lodgment of transfer and dematerialisation requests. The window parameters are structured as follows:

Parameter: Details
Window Period: February 5, 2026 to February 4, 2027
Applicable Cases: Transfer deeds executed before April 1, 2019
Processing Mode: Dematerialised form only
Lock-in Period: One year from transfer registration

Eligibility Criteria

The special window applies specifically to cases where the original transfer deed was executed before April 1, 2019. Two categories of shareholders are eligible for this facility:

  • Previously Lodged Requests: Shareholders whose transfer requests were lodged prior to April 1, 2019 but were subsequently returned, rejected, or remained unattended due to deficiencies in documentation or other procedural reasons
  • Unlodged Requests: Shareholders who did not lodge transfer requests prior to April 1, 2019 and continue to hold the original share certificate along with the duly executed transfer deed

Processing Requirements

Under current SEBI guidelines, all shares re-lodged for transfer during this window will be processed exclusively in dematerialised form. The securities transferred through this mechanism will be subject to specific restrictions:

Restriction Type: Details
Lock-in Duration: One year from registration date
Transfer Restrictions: No transfers during lock-in period
Lien Marking: Prohibited during lock-in period
Pledging: Not permitted during lock-in period

Submission Process

Eligible shareholders must submit their re-lodgment requests along with all requisite documents to the company's Registrar and Share Transfer Agent (RTA). The designated contact details are:

Alankit Assignments Limited
(Unit: IOL Chemicals and Pharmaceuticals Limited)
"Alankit Heights", 4E/2, Jhandewalan Extension
New Delhi - 110 055
Phone: +91-11-23541234, 42541234
Email: rta@alankit.com

Regulatory Compliance

The company submitted the newspaper publication to both NSE (Security Symbol: IOLCP) and BSE (Security Code: 524164) on April 13, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The submission was digitally signed by Abhay Raj Singh, Senior Vice President & Company Secretary, ensuring proper documentation and regulatory adherence.

Shareholders are encouraged to utilise this special window opportunity and ensure timely submission of their transfer requests within the specified timeframe to avoid any procedural complications.

Historical Stock Returns for IOL Chemicals & Pharmaceuticals

1 Day5 Days1 Month6 Months1 Year5 Years
+1.08%+12.99%+27.96%0.0%+41.23%-22.23%

Will SEBI extend similar special windows to other listed companies facing comparable physical securities transfer backlogs?

How might the one-year lock-in period impact IOL Chemicals' stock liquidity and trading volumes in 2027?

What percentage of IOL Chemicals' total shareholding remains in physical form and could potentially utilize this window?

IOL Chemicals & Pharmaceuticals
View Company Insights
View All News
like15
dislike

More News on IOL Chemicals & Pharmaceuticals

1 Year Returns:+41.23%